Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended				9 Months Ended		12 Months Ended
	Jun. 30, 2025	Dec. 31, 2024	Jun. 30, 2024	Dec. 31, 2023	Jun. 30, 2025	Jun. 30, 2024	Sep. 30, 2024
Operating Activities
Net loss	$ 106	$ 312	$ 438	$ (9,358)	$ (31,394)	$ (7,950)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization					2,167	2,310
Write-down of inventory					6,647	1,367
Goodwill impairment					20,353	6,370	$ 6,400
Intangible asset impairment					2,569	1,279
Deferred income taxes					0	(13)
Non-cash share-based compensation expense	300		500		961	1,155
Loss (gain) on sale of fixed assets	45				274	(2,197)
Provision for allowance for credit losses					43	(21)
Changes in operating assets and liabilities:
Accounts receivable					2,899	2,204
Inventories					600	4,695
Other assets					3,057	4,205
Accounts payable					1,477	(1,965)
Accrued income taxes					219	548
Accrued and other liabilities					(1,696)	(4,298)
Contract liabilities					(2,567)	1,274
Net cash provided by operating activities					5,609	8,963
Investing Activities
Purchases of property, plant and equipment					(704)	(5,310)
Proceeds from the sale of property, plant and equipment					12	2,700
Net cash used in investing activities					(692)	(2,610)
Financing Activities
Proceeds from the exercise of stock options					150	28
Payments on long-term debt					(70)	(6,668)
Net cash provided by (used in) financing activities					80	(6,640)
Effect of Exchange Rate Changes on Cash and Cash Equivalents					(520)	337
Net Increase in Cash and Cash Equivalents					4,477	50
Cash and Cash Equivalents, Beginning of Period		$ 11,086		$ 13,133	11,086	13,133	13,133
Cash and Cash Equivalents, End of Period	$ 15,563		$ 13,183		15,563	13,183	$ 11,086
Supplemental Cash Flow Information:
Income tax payments, net					1,297	189
Interest paid					$ 18	$ 498